Previous studies have found that PROM2 was up-regulated in a variety of tumors, such as bladder cancer, pancreatic cancer, melanoma.7,10,22 However, the potential role and mechanism of PROM2 in NSCLC remains unclear. The gene discussed is PROM2; the disease is urinary bladder carcinoma.